Jeffrey Vacirca

Jeffrey Vacirca

Director/Board Member at ASSERTIO HOLDINGS, INC.

Net worth: 83 825 $ as of 31/03/2024

55 year
Health Technology
Consumer Services
Health Services

Profile

Jeffrey L.
Vacirca
is the founder of National Translational Research Group, Inc. (founded in 2011) and holds the title of President.
He is also the founder of New York Cancer Foundation.
Dr. Vacirca's current job(s) include Chairman, CEO & Director-Clinical Research at New York Cancer Specialists (since 2008), Medical Director at The Mount Sinai Hospital (since 2018), Medical Director at AmerisourceBergen Specialty Group LLC (since 2012), Director at American Red Cross in Greater New York, Director at OneOncology LLC (since 2018), Medical Director at International Oncology Network LLC, Director at Community Oncology Alliance, Inc. (starting in 2023), Independent Director at Assertio Holdings, Inc. (starting in 2023), Director at Annexus Health LLC (since 2021), and Associate Clinical Professor at Icahn School of Medicine at Mount Sinai (since 2018).
Dr. Vacirca's former job(s) include Vice Chairman at Odonate, Inc. (2016-2019), Independent Director at Spectrum Pharmaceuticals, Inc. (2018-2023), Independent Director at BeyondSpring, Inc. (2020-2022), and President at Community Oncology Alliance, Inc. (2017-2019).
Dr. Vacirca's education history includes an undergraduate degree from State University of New York at Albany and a doctorate degree from St. Georges University School of Medicine.
Dr. Vacirca is also the founder of New York Cancer Foundation.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
31/07/2023 87,409 ( 0.09% ) 83 825 $ 31/03/2024
31/07/2023 0 ( -.--% ) - $ 31/07/2023

Jeffrey Vacirca active positions

CompaniesPositionStart
ASSERTIO HOLDINGS, INC. Director/Board Member 31/07/2023
Director/Board Member 01/01/2023
International Oncology Network LLC Chief Tech/Sci/R&D Officer -
New York Cancer Foundation Chief Executive Officer -
Chief Tech/Sci/R&D Officer 01/01/2018
Director/Board Member 24/03/2021
Icahn School of Medicine at Mount Sinai Corporate Officer/Principal 01/01/2018
Chief Tech/Sci/R&D Officer 01/01/2012
Chief Executive Officer 01/01/2008
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
All active positions of Jeffrey Vacirca

Former positions of Jeffrey Vacirca

CompaniesPositionEnd
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
See the detail of Jeffrey Vacirca's experience

Training of Jeffrey Vacirca

State University of New York at Albany Undergraduate Degree
St. Georges University School of Medicine Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jeffrey Vacirca's experience

Connections

100 +

1st degree connections

17

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies4
SPECTRUM PHARMACEUTICALS, INC.

Health Technology

BEYONDSPRING INC.

Health Technology

ODONATE, INC.

Health Technology

ASSERTIO HOLDINGS, INC.

Health Technology

Private companies10

Health Services

Distribution Services

Commercial Services

Health Services

International Oncology Network LLC

Health Services

Commercial Services

National Translational Research Group, Inc.

Technology Services

New York Cancer Foundation

See company connections
  1. Stock Market
  2. Insiders
  3. Jeffrey Vacirca